Posted on 09/08/2010 in Dental Supplier News Procter and Gamble has hailed the success of its business strategy for the 2010 fiscal year after reporting better-than-expected annual results.
The health and personal care company saw a five per cent year-on-year net sales growth in the fourth quarter of its 2010 financial year, reaching a total of $18.9 billion (11.8 billion pounds).
This contributed to an overall annual growth of three per cent to $78.9 billion, with oral care playing a key role thanks to improved European sales and several new Crest and Oral-B product launches.
Bob McDonald, the firm's chairman of the board, president and chief executive officer, said the results are indicative of increased investment in new products and marketing initiatives.
He added: "We are executing on all three dimensions of our growth strategy - touching and improving more consumers' lives, in more parts of the world, more completely."
Earlier this year, it was announced that Procter and Gamble would ally with Biolase Technology to launch new light-based oral care devices, to be distributed by Henry Schein. Other news stories from 09/08/2010
Read more in the Zenopa News Archive
How this news is generated
|
